Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announc

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present Data from First-in-Hu

Amylyx Pharmaceuticals NASDAQ: AMLX Co-Chief Executive Officer Justin Klee said the company is prepa

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

[url="]Amylyx Pharmaceuticals, Inc.[/url] (NASDAQ: AMLX) (“Amylyx” or the “Company”) today a

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Poster Presentations a

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Co

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announc

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com

Amylyx Pharmaceuticals NASDAQ: AMLX is preparing for a pivotal Phase 3 readout for AVEXITIDE, its le

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Tr

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports First Quarter 2026 Finan

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announc

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Com

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform

Amylyx Pharmaceuticals (NASDAQ: AMLX) is entering what it described as a pivotal year for its lead p

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present at the 25th Annual Ne

US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, R

HC Wainwright & Co. analyst Andrew S. Fein reiterates Amylyx Pharmaceuticals (NASDAQ:AMLX) wi

Last participant has been randomized and dosed in the LUCIDITY trial of avexitide; LUCIDITY enrolled

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Completion of Enrollme

Guggenheim analyst Seamus Fernandez maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and

Ally Bridge Group NY LLC acquired a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in t

Alpha Wave Global LP increased its position in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) by 18.7%

Amylyx Pharmaceuticals (NASDAQ: AMLX) executives told investors the company entered 2026 with a focu

Amylyx Pharmaceuticals (AMLX) is downgraded from 'Strong Buy' to 'Buy' following the discontinuation

Top Wall Street analysts changed outlook on top names. Check out analyst ratings page for all change

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the co

Shares of Etsy, Inc.

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after repor

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

  On Tuesday, 647 companies set new 52-week lows.